| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/05/2008 | CN101137349A Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 03/05/2008 | CN101134781A Recombinant fusion protein carrying anthrax protective antigens epitope inserted to hepatitis B core antigen protein or its fragment and uses thereof |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134769A Ursodeoxycholic acid entecavir acidamide and preparation method and use thereof |
| 03/05/2008 | CN101134724A 1'-acetoxy chavicol acetate |
| 03/05/2008 | CN101134092A Traditional Chinese medicine compound preparations for treating respiratory disease and method for preparing the same |
| 03/05/2008 | CN101134073A Pharmaceutical composition for treating chronic hepatitis and method for preparing the same |
| 03/05/2008 | CN101134071A Pharmaceutical composition for treating chronic hepatitis and method for preparing the same |
| 03/05/2008 | CN101134070A Hepatitis treating medicine and method for preparing the same |
| 03/05/2008 | CN101134056A Traditional Chinese medicine for preventing and treating baraquet and method of making the same |
| 03/05/2008 | CN101134039A Soya bean lecithin powder medicine and method for preparing the same |
| 03/05/2008 | CN101134035A Application of sophocarpine in the preparing of medicament for treating inflammation caused by influenza B virus |
| 03/05/2008 | CN100373375C System and method for controlling user interface attribute by data |
| 03/05/2008 | CN100372936C I (vibrio cholerae) vaccine candidates and method of their constructing |
| 03/05/2008 | CN100372871C Promoter to IL-18BP, its preparation and use |
| 03/05/2008 | CN100372869C Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372847C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-C] quinolin-4-cyano and 1H-imidazo [4,5-C] quinolin-4-carboxamide intermediates |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
| 03/05/2008 | CN100372571C Chitosan-immune RNA composite formulation and preparation method thereof |
| 03/05/2008 | CN100372569C Dendrimer-photosensitizer complexes for medical applications |
| 03/05/2008 | CN100372566C Targeted delivery of drugs for treatment of viral infections |
| 03/05/2008 | CN100372544C Silkworm sand total alkaloid and preparation thereof |
| 03/05/2008 | CN100372524C Amphotericin B nano preparation |
| 03/04/2008 | US7339089 Transgenic cell comprising human leukocyte antigen binding peptide for use as tools diagnosis, prevention and treatment of cell proliferative disorders; genetic vaccines |
| 03/04/2008 | US7339064 Benzimidazole compound crystal |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338949 Mycobacterial inhibitors |
| 03/04/2008 | US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 02/28/2008 | WO2008024981A1 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 02/28/2008 | WO2008024843A2 Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein |
| 02/28/2008 | WO2008024075A1 Modulators of candida hyphal morphogenesis and uses thereof |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023786A1 Method for producing virus-specific ctl |
| 02/28/2008 | WO2008023662A1 Bacterial strain having immunostimulating activity, and beverage, food and immunostimulating agent comprising the bacterial strain |
| 02/28/2008 | WO2008023453A1 Edwardsiella disease in fish and vaccine for streptococcal disease |
| 02/28/2008 | WO2008022771A1 Amides as sphingomyeline inhibitors |
| 02/28/2008 | WO2008022462A1 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | WO2008009700A8 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2008006979A3 Process for preparing diaminophenothiazinium compounds |
| 02/28/2008 | WO2008000454A3 Composition for the treatment of skin comprising ink sack liquid of cephalopods |
| 02/28/2008 | WO2007147623A3 A novel target in the treatment of cytokine release syndrome |
| 02/28/2008 | WO2007139729A8 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 02/28/2008 | WO2007110678A3 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | US20080051577 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/28/2008 | US20080051424 Heterocyclyl-substituted nonadepsipeptides |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051330 Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses |
| 02/28/2008 | US20080051326 Antiinfective Lipopeptides |
| 02/28/2008 | US20080051323 Chloroquine drug compositions and methods for their synthesis |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | US20080050430 Pharmaceutical compositions and methods for improved bacterial eradication |
| 02/28/2008 | US20080050405 Ringworm Vaccine |
| 02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
| 02/28/2008 | US20080050401 Rescue of Influenza Virus |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050392 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050360 Method of treating a pathological syndrome and a pharmaceutical agent |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050336 Hepatitis C Virus Inhibitors |
| 02/28/2008 | US20080050317 Oleaginous pharmaceutical and cosmetic foam |
| 02/28/2008 | CA2661814A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | CA2661436A1 Isoquinoline, quinazoline and phthalazine derivatives |
| 02/28/2008 | CA2659991A1 Amides as sphingomyeline inhibitors |
| 02/28/2008 | CA2657316A1 Method for improving pharmacokinetics |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892298A1 Streptococcal C5a peptidase vaccine |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891094A2 Scytovirin domain 1 related polypeptides |
| 02/27/2008 | EP1891089A2 Hcv protease inhibitors in combination with food |
| 02/27/2008 | EP1891078A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 02/27/2008 | EP1891071A2 Cyclopropanecarboxylate esters of acyclovir |
| 02/27/2008 | EP1891027A1 Processes for the preparation of stable polymorphic form i of ritonavir |
| 02/27/2008 | EP1891008A1 Oxindoles as kinase inhibitors |
| 02/27/2008 | EP1890997A1 Methods of purifying tigecycline |
| 02/27/2008 | EP1890707A2 Nutritional supplement with colostrum and epa or dha or gla |
| 02/27/2008 | EP1890681A2 Method and composition for pharmaceutical product |
| 02/27/2008 | EP1558616B1 Meso-substituted porphyrins |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1496873B1 Chewable soft capsule |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1163000B1 Vaccine against antigens from bacteriae |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |